Monkeypox: NCDC Registers 15 New Cases

Monkeypox: NCDC registers 15 new cases

Dr Chikwe Ihekweazu, Director-General, Nigeria Centre for Disease Control (NCDC), on Tuesday in Abuja said 59 suspected cases and 15 confirmed cases of Monkeypox have been registered.

Ihekweazu said this while reacting to the Dallas, Texas resident who recently returned from Nigeria and tested positive to the disease.

It was the first confirmed case of the virus in the U.S. since 2003.

Laboratory tests confirmed that the patient was infected with a strain of the virus mainly seen in West Africa, which included Nigeria.

Ihekweazu said that just as the agency responded to other epidemic prone diseases in the country, an outbreak would be declared when there was a large cluster of monkeypox cases that constituted an emergency.

“The Federal Government was notified of the situation in Texas, through the International Health Regulations (IHR), who reported a case of monkeypox disease diagnosed in a patient who had recently visited Nigeria.

“Since the re-emergence of monkeypox in the country in September 2017, the agency has continued to receive reports and responses to sporadic cases of the disease from states across the country.

“We have been working closely with state health ministries to strengthen monkeypox disease surveillance and response in the country.

“We work with Enhanced Monkeypox Surveillance Project where we have been training health workers across states to rapidly detect and manage cases.

“Our initial focus is on the states with the highest number of cases – Delta, Bayelsa, Rivers and Lagos.

“We will continue working with all states to strengthen monkeypox prevention, detection and control in Nigeria,” he explained.

He urged Nigerians to continue adhering to precautions that protected them from monkeypox and other infectious diseases.

“If you feel ill or have a sudden rash, please visit a hospital for diagnosis and management,” he advised.

Monkeypox, which is in the same family of viruses as smallpox, is a rare but potentially deadly viral infection that begins with flu-like symptoms and progresses to a rash on the face and body.